ARTICLES BY LOUIS

• A New Year For Novo Nordisk’s Wegovy Supply Challenges

  12/8/2022

  Those who follow this kind of news – and some who normally don’t – jumped on Novo Nordisk and Catalent for what is in fact a significant supply-chain challenge that came to light at the turn of the New Year. Now, a year later, we, too, take this up, but from a different perspective than previously presented.

• Prince Of Spray Drying Returns As Earl Of Dispersion

  12/7/2022

  Tim Scott traces the arc of spray drying from its advent to today’s advanced amorphous dispersion technology. Now he's back at it again, pushing the technology to even higher levels of accessibility and productivity.

• ATMP Report Identifies Outsourcing Realities

  11/28/2022

  A report from from The American Society of Gene & Cell Therapy (ASGCT) and Informa Pharma Intelligence speaks volumes about outsourcing without ever mentioning the word. Or “CDMO.” So we'll employ our synergistic powers to connect the data to your development and manufacturing relationships.

• Are You Ready For A Recession?

  11/21/2022

  CDMOs have facility utilization and operating profits. Biotechs have burn rates and investors. Pharma has budgets and profitability. The state of the economy affects all of these. In the past, we’ve seen outsourcing behaviors change acutely during economic downturns. Here's part one in a series with industry executives to get you ready for a downturn.

• Who’s Afraid Of Their CDMO Getting Acquired?

  11/16/2022

  “It seems as soon as a new boutique or smaller CDMO – especially in the biologic space – can get established, one of the big guys is eating them up,” says Kelly Creighton, Citrus Pharmaceuticals. In this hard-hitting editorial, Creighton provides readers with some positive thoughts and solutions to overcome the challenges M&A may bring.

• CDMOs Still Limiting Access: COVID Or Convenience?

  11/11/2022

  Kelly Creighton of Citius Pharmaceuticals, Inc., likes to stay close to the CDMOs comprising his outsourcing strategy. "Prior to COVID," he says, "We were constantly going onsite." But now, is the continuing stringent policy regarding customer visits actually still wrapped around COVID, or are CDMOs staying restrictive for other reasons?

• Small Molecules And The Cost Of CDMO Services

  11/10/2022

  We should never take our eyes off the small-molecule market, and two surveys from ISR Reports suggests some interesting developments when it comes to costs and attitudes for outsourcing services in the sector.

• Safety Led Lilly To Leadership In Continuous Manufacturing

  11/1/2022

  Thanks to leaders such as Eli Lilly – and today’s contracting industry – we’ve reached a point where big and small organizations can receive the external help needed to employ various continuous manufacturing and processing strategies.

• The Final 4 Core Values For Working In The Outsourcing Space

  10/24/2022

  We’ve reached the final four of the Eight Core Values devised some years ago to propel the outsourcing industry to the highest standards of internal and external excellence. Not only do they remain applicable to any business today, they may be needed more than ever. 

• Driving CDMO Performance And Customer Service

  10/21/2022

  This is part two in our review of the Eight Core Values that helped establish the outsourcing industry as we know it today. Here we cover "High Performance," "Quality," and "Customer Satisfaction And Service." Does your CDMO have what it takes? Here's how to measure them against the ideal.